Advanced MedAesthetic Partners Fuels Blush Med Spa's Growth with New Location in Orange, CT
Blush Med Spa has been at the forefront of non-invasive cosmetic treatments for over 15 years, offering a full suite of services, including Botox, Xeomin, dermal fillers, laser treatments, microneedling, and body contouring. Known for blending medical expertise with an artistic approach, Blush empowers clients to enhance their natural beauty through personalized treatment plans.
"This expansion marks an exciting new chapter for Blush," said Camille Karalekas, Blush Med Spa Founder. "We've seen incredible demand for our services, and thanks to AMP's partnership, we're able to bring our signature blend of innovation and patient care to Orange. We look forward to welcoming new clients and continuing to raise the bar in medical aesthetics."
AMP's strategic partnership model is designed to elevate industry-leading practices by providing operational resources, business development expertise, and clinical training—all while preserving each practice's unique identity. By investing in Blush Med Spa's expansion, AMP is not just opening another location—it's reinforcing its commitment to building a strong, sustainable future for medical aesthetics.
"This is more than just a new location—it's a testament to the power of smart growth," said Nicole Chiaramonte, CEO of AMP. "Blush Med Spa's success is a reflection of its dedication to excellence, and we're proud to support its continued expansion. Orange, CT, is the next step in our journey to bring world-class aesthetic care to more communities."
With AMP's rapid expansion and Blush Med Spa's growing influence, this new location creates opportunities not only for clients seeking the latest in aesthetic care but also for top medical professionals looking to join a dynamic, forward-thinking team. As AMP continues to scale, it remains focused on fostering innovation, investing in talent, and setting new industry standards.
For more information about AMP's partnerships and expansion, visit www.weramp.com.
ABOUT AMPAdvanced MedAesthetic Partners (AMP) invests in medical aesthetic practices to drive growth and expansion through strategic partnerships. Our mission is to help practices scale durable businesses while maintaining their unique identity and delivering exceptional care. Leveraging unparalleled expertise, a network of successful entrepreneurs, and a commitment to operational excellence, AMP empowers practices to achieve their long-term vision and thrive in a competitive industry. Learn more at www.weramp.com.
ABOUT LEON CAPITAL GROUPLeon Capital Group (Leon) is a holding company that operates assets in the financial services, healthcare, real estate, and technology industries. Leon is not a private equity fund; it operates as a family holding company overseeing $10 billion of private capital. It takes the lead in conceiving, developing, owning, and operating businesses. Leon started as a modest privately-owned real estate development company in Texas, and has since evolved into a diverse holding company, capable of operating successfully across multiple geographies and industries. Learn more about Leon Capital Group at www.LeonCapitalGroup.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/advanced-medaesthetic-partners-fuels-blush-med-spas-growth-with-new-location-in-orange-ct-302454960.html
SOURCE Advanced Medaesthetic Partners
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
Major development units planned for two Pembrokeshire towns
Three separate applications for 'battery box' units to provide electricity storage during off-peak times have been submitted to Pembrokeshire planners. The three schemes, all made by AMP Clean Energy, seek permission for micro energy storage unit 'battery boxes' on land between Steynton Road and Sheffield Drive and Castle Terrace and Pill Road, Milford Haven; and on a verge at Fishguard Leisure Centre Car Park. A supporting statement accompanying each application says: 'AMP Clean Energy is developing Battery Boxes across the UK to provide a low carbon, flexible and de-centralised store of electricity that benefits local communities, businesses, and homes.' It says the battery boxes import electricity from the local electricity network when demand for electricity is low or when there are high levels of renewable energy available, exporting it back during periods of high demand to help address grid reliability issues prompted by an increase of intermittent (wind and solar) generation of the electricity system. Read more Trial of overnight motorhome and campervan parking in Pembrokeshire approved New holiday lodge plans in Pembrokeshire given green light Plans to build 20-metre high 4G mast near Tenby AMP Clean Energy says it is developing up to 1,250-plus Battery Boxes in the UK over the next three years and, to date, has received planning consent for more than 80 such schemes across the country. It says each box, which takes up roughly two car parking spaces, stores 800kWh of electricity, giving the potential to power 200 homes for four hours where there is a disruption to supply. The statement adds: 'The UK's electricity system was traditionally dominated by a small number of large power stations fuelled by fossil fuel (namely coal and natural gas). However, the system is now becoming increasingly supplied by intermittent sources of renewable energy such as wind and solar power. 'Renewable power generation does not always match when the demand for electricity is highest. To overcome this, we need a more flexible energy system that allows us to shift renewable energy to the periods of the day when the demand for power is at its greatest. 'And as the UK builds more and more renewable projects, increasingly there are times when the amount of renewable electricity on the system is greater than the demand for it.' The three applications will be considered by county planners at a later date.
Business Wire
a day ago
- Business Wire
Evolus Announces Publication of Independent Study in JAMA Dermatology Demonstrating Jeuveau ® as a Top Performer Among Leading Neurotoxins
NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced the publication of a landmark independent study in JAMA Dermatology directly comparing four leading botulinum toxin type A products for the treatment of glabellar lines: Jeuveau ® (prabotulinumtoxinA-xvfs), Botox ® (onabotulinumtoxinA), Dysport ® (abobotulinumtoxinA), and Xeomin ® (incobotulinumtoxinA). In the double-blind, randomized study conducted at the University of Pennsylvania, 143 female participants aged 30 to 65 were treated with FDA-approved doses of either Jeuveau ®, Botox ®, Dysport ®, or Xeomin ®. Using advanced 3-dimensional photogrammetry, researchers quantified dynamic facial strain to objectively measure efficacy at days 3, 30, 90, and 180. Key published findings include: Fast Onset of Action: Jeuveau ® and Dysport ® demonstrated significantly faster visible effects at Day 3 compared to Botox ® and Xeomin ®. Strong Peak Effect: Jeuveau ® achieved the highest peak effect at Day 30, with a median strain reduction of 93%, highlighting its robust performance profile. Long Duration of Effect: Jeuveau ® had significant duration at Day 180 compared with baseline and was significantly more effective than Botox ® at this time point. 'This is an important study as it was independently conducted and utilized a sensitive, validated endpoint designed to eliminate investigator bias in comparing the four neurotoxins,' said Dr. Rui Avelar, Chief Medical Officer and Head of R&D of Evolus. 'The results add to what we observed in our prior head-to-head study with Botox ®, while also offering valuable comparative insights across the broader landscape of aesthetic neurotoxins. The results reinforce what many aesthetic providers already observe in practice, that Jeuveau ® delivers a differentiated performance profile. These data support Jeuveau ® as a modern aesthetic neurotoxin delivering fast onset, strong effect, and long-lasting results.' Since its launch, Jeuveau ® has become the fastest-growing neurotoxin in the U.S. for four consecutive years. Today, it holds over 14% U.S. market share and has penetrated over 50% of aesthetic clinics. Evolus provided funding for this study through an investigator-initiated research grant. As an independent study, Evolus was not involved in the design, protocol development, or in the conduct of the research, each of which was carried out independently by the investigators. About Evolus, Inc. Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau ® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse ™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at and follow us on LinkedIn, X, Instagram or Facebook. Jeuveau ® and Nuceiva ®, are registered trademarks and Evolysse ™ is a trademark of Evolus, Inc. Botox ® (onabotulinumtoxinA) is a registered trademark of Allergan, Inc. Dysport ® (abobotulinumtoxinA) is a registered trademark of Ipsen Biopharma Limited. Xeomin ® (incobotulinumtoxinA) is a registered trademark of Merz Pharma GmbH & Co KGaA.
Yahoo
2 days ago
- Yahoo
Group of Aussies headed for work crisis
Australia's white collar workers will soon be under threat as experts warn the job slow down is 'more complicated' this time around. In its latest release of jobs data, the ABS revealed Australia's unemployment rate soared to 4.3 per cent, its highest level since the post pandemic recovery. The falls were broad-based with NSW, Queensland, Western Australia and the Northern Territory all seeing strong spikes in unemployment. Drilling down into the figures, so far it has impacted blue collar workers disproportionately, but it is expected major technological advancements will flip the script in the next year. ABS data released in June shows workers living in Sydney's west, including the Parramatta district have an unemployment rate of 5.7 per cent, compared to Sutherland in Sydney's south, which recorded just a 2.3 per cent unemployment rate. Meanwhile, those in Melbourne Inner East and South have seen a 0.2 per cent spike in unemployment while those in Geelong have actually seen the market strengthen. AMP chief economist Shane Oliver said this could change as unemployment becomes 'more complicated this time' as the number of new public sector roles drops and AI use becomes more commonplace within corporations. 'Normally it's the more cyclical parts that are vulnerable including manufacturing, construction, and retail,' he told NewsWire. 'This time could be a little different.' 'You've also got the overlay of AI coming in which suggests there could be more of an impact on white collar jobs, as companies seek to lower their costs through the emergence of the new technology.' Seek's monthly jobs data also points to less need for white collar workers. The construction sector was the only area that recorded a lift in job ads in June as a whole, while there were some pockets in growth for those in professional services including markets and communications and accounting. Meanwhile available information and communications technology positions continued to decline, with job ads falling 3.5 per cent in June or 10.5 per cent for the year. Advertised positions in the sector have now fallen below covid levels. Seek senior economist Blair Chapman said there had been a 5.5 per cent fall in job ads, and an increase in the number of Australians looking for work. 'On the other side of the market, applications per job ad have never been higher, and have now surpassed the peak recorded in 2020 when job ads were at their lowest,' he said. 'This rise is due to an increased candidate pool, rather than candidates applying for more roles. 'Over the past couple of years more Australians have taken on a second job, or are looking to do so, and more workers have entered or re-entered the workforce. 'This is likely in response to increased living costs, and as a result, competition is extremely strong for most available roles.'
